ICD-10-CM Code B38.7

Disseminated coccidioidomycosis

Version 2020 Billable Code

Valid for Submission

B38.7 is a billable code used to specify a medical diagnosis of disseminated coccidioidomycosis. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code B38.7 might also be used to specify conditions or terms like coccidiomycosis liver or disseminated coccidioidomycosis.

ICD-10:B38.7
Short Description:Disseminated coccidioidomycosis
Long Description:Disseminated coccidioidomycosis

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code B38.7:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Generalized coccidioidomycosis

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code B38.7 are found in the index:


Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Coccidiomycosis liver
  • Disseminated coccidioidomycosis

Convert B38.7 to ICD-9

  • 114.3 - Progress coccidioid NEC (Approximate Flag)

Code Classification

  • Certain infectious and parasitic diseases (A00–B99)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Information for Patients


Valley Fever

Valley Fever is a disease caused by a fungus (or mold) called Coccidioides. The fungi live in the soil of dry areas like the southwestern U.S. You get it from inhaling the spores of the fungus. The infection cannot spread from person to person.

Anyone can get Valley Fever. But it's most common among older adults, especially those 60 and older. People who have recently moved to an area where it occurs are at highest risk for infection. Other people at higher risk include

  • Workers in jobs that expose them to soil dust. These include construction workers, agricultural workers, and military forces doing field training.
  • African Americans and Asians
  • Women in their third trimester of pregnancy
  • People with weak immune systems

Valley Fever is often mild, with no symptoms. If you have symptoms, they may include a flu-like illness, with fever, cough, headache, rash, and muscle aches. Most people get better within several weeks or months. A small number of people may develop a chronic lung or widespread infection.

Valley Fever is diagnosed by testing your blood, other body fluids, or tissues. Many people with the acute infection get better without treatment. In some cases, doctors may prescribe antifungal drugs for acute infections. Severe infections require antifungal drugs.

Centers for Disease Control and Prevention


[Learn More]